Aberrant epigenetic landscape in intellectual disability

Progress in Brain Research

Volumn 197, Issue , 2012, Pages 53-71

  Sanchez Mut, J V ^a   Huertas, D ^a   Esteller, M ^a  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

Author keywords

Brain function; DNA methylation; Down syndrome; Epigenetics; Histone modification

Indexed keywords

ATRX PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; BUTYRIC ACID; CELL DNA; DNA METHYLTRANSFERASE; HISTONE; HISTONE DEACETYLASE INHIBITOR; LYSINE; METHYL CPG BINDING PROTEIN 2; PHENYLBUTYRATE; PROTEIN; PROTEIN SWI; TRANSCRIPTION FACTOR SNF; TRICHOSTATIN A; UNCLASSIFIED DRUG; VALPROIC ACID; VORINOSTAT;

ALPHA THALASSEMIA; ARTICLE; BRAIN FUNCTION; CHROMATIN STRUCTURE; CPG ISLAND; DNA METHYLATION; DNA MODIFICATION; DOWN SYNDROME; ENZYME INHIBITION; EPIGENETICS; EPILEPSY; GENE EXPRESSION REGULATION; GENE LOCATION; GENETIC DISORDER; HISTONE ACETYLATION; HISTONE METHYLATION; HISTONE MODIFICATION; HUMAN; INTELLECTUAL IMPAIRMENT; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RETT SYNDROME; RUBINSTEIN SYNDROME; SIGNAL TRANSDUCTION; X LINKED MENTAL RETARDATION;

EID: 84860348726     PISSN: 00796123     EISSN: 18757855     Source Type: Book Series    
DOI: 10.1016/B978-0-444-54299-1.00004-2     Document Type: Chapter

References (149)

1. Agarwal N., Hardt T., Brero A., Nowak D., Rothbauer U., Becker A., et al. MeCP2 interacts with HP1 and modulates its heterochromatin association during myogenic differentiation. Nucleic Acids Research 2007, 35:5402-5408.
2. Alarcón J.M., Malleret G., Touzani K., Vronskaya S., Ishii S., Kandel E.R., et al. Chromatin acetylation, memory, and LTP are impaired in CBP+/- mice: A model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration. Neuron 2004, 42(6):947-959.
3. Amir R.E., Van den Veyver I.B., Wan M., Tran C.Q., Francke U., Zoghbi H.Y. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nature Genetics 1999, 23:185-188.
4. Azevedo F.A., Carvalho L.R., Grinberg L.T., Farfel J.M., Ferretti R.E., Leite R.E., et al. Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain. The Journal of Comparative Neurology 2009, 513(5):532-541.
5. Bakshi R., Hassan M.Q., Pratap J., Lian J.B., Montecino M.A., van Wijnen A.J., et al. The human SWI/SNF complex associates with RUNX1 to control transcription of hematopoietic target genes. Journal of Cellular Physiology 2010, 225(2):569-576.
6. Balmer D., Arredondo J., Samaco R.C., LaSalle J.M. MECP2 mutations in Rett syndrome adversely affect lymphocyte growth, but do not affect imprinted gene expresión in blood or brain. Human Genetics 2002, 110:545-552.
7. Bannister A.J., Kouzarides T. Regulation of chromatin by histone modifications. Cell Research 2011, 21(3):381-395.
8. Barski A., Cuddapah S., Cui K., Roh T.Y., Schones D.E., Wang Z., et al. High-resolution profiling of histone methylations in the human genome. Cell 2007, 129(4):823-837.
9. Bartholdi D., Roelfsema J.H., Papadia F., Breuning M.H., Niedrist D., Hennekam R.C., et al. Genetic heterogeneity in Rubinstein-Taybi syndrome: Delineation of the phenotype of the first patients carrying mutations in EP300. Journal of Medical Genetics 2007, 44(5):327-333.
10. Baumann C., De La Fuente R. ATRX marks the inactive X chromosome (Xi) in somatic cells and during imprinted X chromosome inactivation in trophoblast stem cells. Chromosoma 2009, 18:209-222.
11. Berger S.L., Kouzarides T., Shiekhattar R., Shilatifard A. An operational definition of epigenetics. Genes & Development 2009, 23(7):781-783.
12. Bérubé N.G., Smeenk C.A., Picketts D.J. Cell cycle-dependent phosphorylation of the ATRX protein correlates with changes in nuclear matrix and chromatin association. Human Molecular Genetics 2000, 9:539-547.
13. Best T.K., Siarey R.J., Galdzicki Z. Ts65Dn, a mouse model of Down syndrome, exhibits increased GABAB-induced potassium current. Journal of Neurophysiology 2007, 97(1):892-900.
14. Brero A., Easwaran H.P., Nowak D., Grunewald I., Cremer T., Leonhardt H., et al. Methyl CpG-binding proteins induce large-scale chromatin reorganization during terminal differentiation. The Journal of Cell Biology 2005, 169:733-743.
15. Cao X., Yeo G., Muotri A.R., Kuwabara T., Gage F.H. Noncoding RNAs in the mammalian central nervous system. Annual Review of Neuroscience 2006, 29:77-103.
16. Cardoso C., Timsit S., Villard L., Khrestchatisky M., Fontes M., Colleaux L. Specific interaction between the XNP/ATR-X gene product and the SET domain of the human EZH2 protein. Human Molecular Genetics 1998, 7:679-684.
17. Chahrour M., Jung S.Y., Shaw C., Zhou X., Wong S.T., Qin J., et al. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 2008, 320:1224-1229.
18. Chan A., Shea T.B. Supplementation with apple juice attenuates presenilin-1 overexpression during dietary and genetically-induced oxidative stress. Journal of Alzheimer's Disease 2006, 10:353-358.
19. Chao H.T., Chen H., Samaco R.C., Xue M., Chahrour M., Yoo J., et al. Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature 2010, 468(7321):263-269.
20. Chen R.Z., Akbarian S., Tudor M., Jaenisch R. Deficiency of metil-CpG binding protein-2 in CNS neurons result in a Rett-like phenotype in mice. Nature Genetics 2001, 27:327-331.
21. Chodavarapu R.K., Feng S., Bernatavichute Y.V., Chen P.Y., Stroud H., Yu Y., et al. Relationship between nucleosome positioning and DNA methylation. Nature 2010, 466(7304):388-392.
22. Choi J.K. Contrasting chromatin organization of CpG islands and exons in the human genome. Genome Biology 2010, 11(7):R70. (Epub 2010 July 5).
23. Choy M.K., Movassagh M., Goh H.G., Bennett M.R., Down T.A., Foo R.S. Genome-wide conserved consensus transcription factor binding motifs are hyper-methylated. BMC Genomics 2010, 11:519.
24. Collins A.L., Levenson J.M., Vilaythong A.P., Richman R., Armstrong D.L., Noebels J.L., et al. Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Human Molecular Genetics 2004, 13:2679-2689.
25. De La Fuente R., Viveiros M.M., Wigglesworth K., Eppig J.J. ATRX, a member of the SNF2 family of helicase/ATPases, is required for chromosome alignment and meiotic spindle organization in metaphase II stage Mouse oocytes. Developmental Biology 2004, 272:1-14.
26. Deaton A.M., Bird A. CpG islands and the regulation of transcription. Genes & Development 2011, 25(10):1010-1022. (Review).
27. Dorfman D.M., Greisman H.A., Shahsafaei A. Loss of expression of the WNT/beta-catenin-signaling pathway transcription factors lymphoid enhancer factor-1 (LEF-1) and T cell factor-1 (TCF-1) in a subset of peripheral T cell lymphomas. The American Journal of Pathology 2003, 162(5):1539-1544.
28. Dorsey S.G., Bambrick L.L., Balice-Gordon R.J., Krueger B.K. Failure of brain-derived neurotrophic factor-dependent neuron survival in mose trisomy 16. The Journal of Neuroscience 2002, 22:2571-2578.
29. Eisen J.A., Sweder K.S., Hanawalt P.C. Evolution of the SNF2 family of proteins: Subfamilies with distinct sequences and functions. Nucleic Acids Research 1995, 23:2715-2723.
30. Elango N., Yi S.V. DNA methylation and structural and functional bimodality of vertebrate promoters. Molecular Biology and Evolution 2008, 25(8):1602-1608.
31. Eroglu B., Wang G., Tu N., Sun X., Mivechi N.F. Critical role of Brg1 member of the SWI/SNF chromatin remodeling complex during neurogenesis and neural crest induction in zebrafish. Developmental Dynamics 2006, 235(10):2722-2735.
32. Esteller M. Rett syndrome: The first forty years: 1966-2006. Epigenetics 2007, 2:1.
33. Eustermann S., Yang J.C., Law M.J., Amos R., Chapman L.M., Jelinska C., et al. Combinatorial readout of histone H3 modifications specifies localization of ATRX to heterochromatin. Nature Structural & Molecular Biology 2011, 18:777-782.
34. Feng J., Chang H., Li E., Fan G. Dynamic expression of de novo DNA methyltransferases Dnmt3a and Dnmt3b in the central nervous system. Journal of Neuroscience Research 2005, 79(6):734-746.
35. Feng J., Zhou Y., Campbell S.L., Le T., Li E., Sweatt J.D., et al. Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons. Nature Neuroscience 2010, 13(4):423-430.
36. Ficz G., Branco M.R., Seisenberger S., Santos F., Krueger F., Hore T.A., et al. Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature 2011, 473(7347):398-402.
37. Fraga M.F., Ballestar E., Paz M.F., Ropero S., Setien F., Ballestar M.L., et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proceedings of the National Academy of Sciences of the United States of America 2005, 102(30):10604-10609.
38. Fuks F., Hurd P.J., Wolf D., Nan X., Bird A.P., Kouzarides T. The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. The Journal of Biological Chemistry 2003, 278:4035-4040.
39. Fukuchi M., Nii T., Ishimaru N., Minamino A., Hara D., Takasaki I., et al. Valproic acid induces up- or down-regulation of gene expression responsible for the neuronal excitation and inhibition in rat cortical neurons through its epigenetic actions. Neuroscience Research 2009, 65:35-43.
40. Gaub P., Tedeschi A., Puttagunta R., Nguyen T., Schmandke A., Di Giovanni S. HDAC inhibition promotes neuronal outgrowth and counteracts growth cone collapse through CBP/p300 and P/CAF-dependent p53 acetylation. Cell Death & Differentiation 2010, 17(9):1392-1408.
41. Ghosh R.P., Horowitz-Scherer R.A., Nikitina T., Shlyakhtenko L.S., Woodcock C.L. MeCP2 binds cooperatively to its substrate and competes with histone H1 for chromatin binding sites. Molecular and Cellular Biology 2010, 30:4656-4670.
42. Gibbons R.J., Brueton L., Buckle V.J., Burn J., Clayton-Smith J., Davison B.C., et al. Clinical and hematologic aspects of the X-linked alpha-thalassemia/mental retardation syndrome (ATR-X). American Journal of Medical Genetics 1995, 55:288-299.
43. Gibbons R.J., Wada T., Fisher C.A., Malik N., Mitson M.J., Steensma D.P., et al. Mutations in the chromatin-associated protein ATRX. Human Mutation 2008, 29:796-802.
44. Gibbons R.J., McDowell T.L., Raman S., O'Rourke D.M., Garrick D., Ayyub H., et al. Mutations in ATRX, encoding a SWI/SNF-like protein, cause diverse changes in the pattern of DNA methylation. Nature Genetics 2000, 24(4):368-371.
45. Glaros S., Cirrincione G.M., Muchardt C., Kleer C.G., Michael C.W., Reisman D. The reversible epigenetic silencing of BRM: Implications for clinical targeted therapy. Oncogene 2007, 26:7058-7066.
46. Goldberg A.D., Banaszynski L.A., Noh K.M., Lewis P.W., Elsaesser S.J., Stadler S., et al. Distinct factors control histone variante H3.3 localization at specific genomic regions. Cell 2010, 140:678-691.
47. Guan J.S., Haggarty S.J., Giacometti E., Dannenberg J.H., Joseph N., Gao J., et al. HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 2009, 459(7243):55-60.
48. Guo J.U., Su Y., Zhong C., Ming G.L., Song H. Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell 2011, 145(3):423-434. (Epub 2011 April 14).
49. Guo X., Williams J.G., Schug T.T., Li X. DYRK1A and DYRK3 promote cell survival through phosphorylation and activation of SIRT1. The Journal of Biological Chemistry 2010, 285(17):13223-13232. (Epub 2010 February 18).
50. Gupta S., Kim S.Y., Artis S., Molfese D.L., Schumacher A., Sweatt J.D., et al. Histone methylation regulates memory formation. The Journal of Neuroscience 2010, 30(10):3589-3599.
51. Guy J., Cheval H., Selfridge J., Bird A. The role of MeCP2 in the brain. Annual Review of Cell and Developmental Biology 2011, 27:631-652.
52. Guy J., Gan J., Selfridge J., Cobb S., Bird A. Reversal of neurological defects in a mouse model of Rett syndrome. Science 2007, 315:1143-1147.
53. Guy J., Hendrich B., Holmes M., Martin J.E., Bird A. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nature Genetics 2001, 27:322-326.
54. Hagebeuk E.E., Koelman J.H., Duran M., Abeling N.G., Vyth A., Poll-The B.T. Clinical and electroencephalographic effects of folinic acid treatment in Rett syndrome patients. Journal of Child Neurology 2011, 26(6):718-723.
55. Harikrishnan K.N., Chow M.Z., Baker E.K., Pal S., Bassal S., Brasacchio D., et al. Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing. Nature Genetics 2005, 37:254-264.
56. Hattori M., Fujiyama A., Taylor T.D., Watanabe H., Yada T., Park H.S., et al. Chromosome 21 mapping and sequencing consortium. The DNA sequence of human chromosome 21. Nature 2000, 405(6784):311-319.
57. Heintzman N.D., Stuart R.K., Hon G., Fu Y., Ching C.W., Hawkins R.D., et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nature Genetics 2007, 39(3):311-318.
58. Hon G., Wang W., Ren B. Discovery and annotation of functional chromatin signatures in the human genome. PLoS Computational Biology 2009, 5(11):e1000566.
59. Huang H., Rambaldi I., Daniels E., Featherstone M. Expression of the Wdr9 gene and protein products during mouse development. Developmental Dynamics 2003, 227(4):608-614.
60. Huff J.T., Plocik A.M., Guthrie C., Yamamoto K.R. Reciprocal intronic and exonic histone modification regions in humans. Nature Structural and Molecular Biology 2010, 17(12):1495-1499.
61. Iqbal K., Jin S.G., Pfeifer G.P., Szabó P.E. Reprogramming of the paternal genome upon fertilization involves genome-wide oxidation of 5-methylcytosine. Proceedings of the National Academy of Sciences of the United States of America 2011, 108(9):3642-3647.
62. Iwase S., Xiang B., Ghosh S., Ren T., Lewis P.W., Cochrane J.C., et al. ATRX ADD domain links an atypical histone methylation recognition mechanism to human mental-retardation syndrome. Nature Structural and Molecular Biology 2011, 18:769-776.
63. Jeffery L., Nakielny S. Components of the DNA methylation system of chromatin control are RNA-binding proteins. The Journal of Biological Chemistry 2004, 279:49479-49487.
64. Jentarra G.M., Olfers S.L., Rice S.G., Srivastava N., Homanics G.E., Blue M., et al. Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome/X-linked mental retardation. BMC Neuroscience 2010, 11:19.
65. Jeong S., Liang G., Sharma S., Lin J.C., Choi S.H., Han H., et al. Selective anchoring of DNA methyltransferases 3A and 3B to nucleosomes containing methylated DNA. Molecular and Cellular Biology 2009, 29(19):5366-5376.
66. Jin S.G., Wu X., Li A.X., Pfeifer G.P. Genomic mapping of 5-hydroxymethylcytosine in the human brain. Nucleic Acids Research 2011, 39(12):5015-5024. (Epub 2011 March 4).
67. Johnson M.B., Kawasawa Y.I., Mason C.E., Krsnik Z., Coppola G., Bogdanović D., et al. Functional and evolutionary insights into human brain development through global transcriptome analysis. Neuron 2009, 62(4):494-509.
68. Jones P.L., Veenstra G.J., Wade P.A., Vermaak D., Kass S.U., Landsberger N., et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nature Genetics 1998, 19:187-191.
69. Kalkhoven E. CBP and p300: HATs for different occasions. Biochemical Pharmacology 2004, 68:1145-1155.
70. Kaufmann W.E., Jarrar M.H., Wang J.S., Lee Y.J., Reddy S., Bibat G., et al. Histone modifications in Rett syndrome lymphocytes: A preliminary evaluation. Brain & Development 2005, 27:331-339.
71. Kerkel K., Schupf N., Hatta K., Pang D., Salas M., Kratz A., et al. Altered DNA methylation in leukocytes with trisomy 21. PLoS Genetics 2010, 6(11):e1001212.
72. Kernohan K.D., Jiang Y., Tremblay D.C., Bonvissuto A.C., Eubanks J.H., Mann M.R., et al. ATRX partners with cohesin and MeCP2 and contributes to developmental silencing of imprinted genes in the brain. Developmental Cell 2010, 18:191-202.
73. Klein C.J., Botuyan M.V., Wu Y., Ward C.J., Nicholson G.A., Hammans S., et al. Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss. Nature Genetics 2011, 43(6):595-600.
74. Klose R.J., Bird A.P. MeCP2 behaves as an elongated monomer that does not stably associate with the Sin3a chromatin remodeling complex. The Journal of Biological Chemistry 2004, 279:46490-46496.
75. Koh K.P., Yabuuchi A., Rao S., Huang Y., Cunniff K., Nardone J., et al. Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells. Cell Stem Cell 2011, 8(2):200-213.
76. Korzus E., Rosenfeld M.G., Mayford M. CBP histone acetyltransferase activity is a critical component of memory consolidation. Neuron 2004, 42:961-972.
77. Kourmouli N., Sun Y.M., van der Sar S., Singh P.B., Brown J.P. Epigenetic regulation of mammalian pericentric heterochromatin in vivo by HP1. Biochemical and Biophysical Research Communications 2005, 337:901-907.
78. Kramer J.M., Kochinke K., Oortveld M.A., Marks H., Kramer D., de Jong E.K., et al. Epigenetic regulation of learning and memory by Drosophila EHMT/G9a. PLoS Biology 2011, 9(1):e1000569.
79. Kuhn D.E., Nuovo G.J., Terry A.V., Martin M.M., Malana G.E., Sansom S.E., et al. Chromosome 21-derived microRNAs provide an etiological basis for aberrant protein expression in human Down syndrome brains. The Journal of Biological Chemistry 2010, 285(2):1529-1543.
80. Lechner M.S., Schultz D.C., Negorev D., Maul G.G., Rauscher F.J. The mammalian hetrochromatin protein 1 binds diverse nuclear proteins through a common motif that targets the chromoshadow domain. Biochemical and Biophysical Research Communications 2005, 331:929-937.
81. Lee J., Hagerty S., Cormier K.A., Kim J., Kung A.L., Ferrante R.J., et al. Monoallele deletion of CBP leads to pericentromeric heterochromatin condensation through ESET expression and histone H3 (K9) methylation. Human Molecular Genetics 2008, 17(12):1774-1782.
82. Lein E.S., Hawrylycz M.J., Ao N., Ayres M., Bensinger A., Bernard A., et al. Genome-wide atlas of gene expression in the adult mouse brain. Nature 2007, 445(7124):168-176.
83. Leonard H., Downs J., Jian L., Bebbington A., Jacoby P., Nagarajan L., et al. Valproate and risk of fracture in Rett syndrome. Archives of Disease in Childhood 2010, 95:444-448.
84. Lepagnol-Bestel A.M., Zvara A., Maussion G., Quignon F., Ngimbous B., Ramoz N., et al. DYRK1A interacts with the REST/NRSF-SWI/SNF chromatin remodelling complex to deregulate gene clusters involved in the neuronal phenotypic traits of Down syndrome. Human Molecular Genetics 2009, 18(8):1405-1414.
85. Levenson J.M., O'Riordan K.J., Brown K.D., Trinh M.A., Molfese D.L., Sweatt J.D. Regulation of histone acetylation during memory formation in the hippocampus. The Journal of Biological Chemistry 2004, 279(39):40545-40559.
86. Lewis P.W., Elsaesser S.J., Noh K.M., Stadler S.C., Allis C.D. Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:14075-14078.
87. Lewis J.D., Meehan R.R., Henzel W.J., Maurer-Fogy I., Jeppesen P., Klein F., et al. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 1992, 69:905-914.
88. Lioy D.T., Garg S.K., Monaghan C.E., Raber J., Foust K.D., Kaspar B.K., et al. A role for glia in the progression of Rett's syndrome. Nature 2011, 475(7357):497-500.
89. Lubin F.D. Epigenetic gene regulation in the adult mammalian brain: Multiples role in memory formation. Neurobiology of Learning and Memory 2011, 96:68-78.
90. Ma D.K., Jang M.H., Guo J.U., Kitabatake Y., Chang M.L., Pow-Anpongkul N., et al. Neuronal activity-induced Gadd45b promotes epigenetic DNA demethylation and adult neurogenesis. Science 2009, 323(5917):1074-1077.
91. Mao R., Wang X., Spitznagel E.L., Frelin L.P., Ting J.C., Ding H., et al. Primary and secondary transcriptional effects in the developing human Down syndrome brain and heart. Genome Biology 2005, 6(13):R107.
92. Meilinger D., Fellinger K., Bultmann S., Rothbauer U., Bonapace I.M., Klinkert W.E., et al. Np95 interacts with de novo DNA methyltransferases, Dnmt3a and Dnmt3b, and mediates epigenetic silencing of the viral CMV promoter in embryonic stem cells. EMBO Reports 2009, 10(11):1259-1264. (Epub 2009 October 2).
93. Miller C.A., Gavin C.F., White J.A., Parrish R.R., Honasoge A., Yancey C.R., et al. Cortical DNA methylation maintains remote memory. Nature Neuroscience 2010, 13(6):664-666.
94. Nagarajan R.P., Hogart A.R., Gwye Y., Martin M.R., LaSalle J.M. Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation. Epigenetics 2006, 1(4):e1-e11.
95. Nan X., Campoy F.J., Bird A. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 1997, 88:471-481.
96. Nan X., Hou J., Maclean A., Nasir J., Lafuente M.J., Shu X., et al. Interaction between chromatin proteins MECP2 and ATRX is disrupted by mutations that cause inherited mental retardation. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:2709-2714.
97. Nan X., Ng H.H., Johnson C.A., Laherty C.D., Turner B.M., Eisenman R.N., et al. Transcriptional repression by the metil-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 1998, 393:386-389.
98. Nelson E.D., Bal M., Kavalali E.T., Monteggia L.M. Selective impact of MeCP2 and associated histone deacetylases on the dynamics of evoked excitatory neurotransmission. Journal of Neurophysiology 2011, 106:193-201.
99. Ooi S.K., Qiu C., Bernstein E., Li K., Jia D., Yang Z., et al. DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature 2007, 448(7154):714-717.
100. Ormazabal A., Artuch R., Vilaseca M.A., Aracil A., Pineda M. Cerebrospinal fluid concentrations of folate, biogenic amines and pterins in Rett syndrome: treatment with folinic acid. Neuropediatrics 2005, 36(6):380-385.
101. Otani J., Nankumo T., Arita K., Inamoto S., Ariyoshi M., Shirakawa M. Structural basis for recognition of H3K4 methylation status by the DNA methyltransferase 3A ATRX-DNMT3-DNMT3L domain. EMBO Reports 2009, 10:1235-1241.
102. Palini S., De Stefani S., Scala V., Dusi L., Bulletti C. Epigenetic regulatory mechanisms during preimplantation embryo development. Annals of the New York Academy of Sciences 2011, 1221:54-60. 10.1111/j.1749-6632.2010.05937.x.
103. Pankotai T., Komonyi O., Bodai L., Ujfaludi Z., Muratoglu S., Ciurciu A., et al. The homologous Drosophila transcriptional adaptors ADA2a and ADA2b are both required for normal development but have different functions. Molecular and Cellular Biology 2005, 25(18):8215-8227.
104. Park J., Oh Y., Chung K.C. Two key genes closely implicated with the neuropathological characteristics in Down syndrome: DYRK1A and RCAN1. BMB Reports 2009, 42(1):6-15.
105. Pogribna M., Melnyk S., Pogribny I., Chango A., Yi P., James S.J. Homocysteine metabolism in children with Down syndrome: In vitro modulation. The American Journal of Human Genetics 2001, 69(1):88-95.
106. Ramirez-Carrozzi V.R., Braas D., Bhatt D.M., Cheng C.S., Hong C., Doty K.R., et al. A unifying model for the selective regulation of inducible transcription by CpG islands and nucleosome remodeling. Cell 2009, 138(1):114-128.
107. Rath A., Naryanan T.J., Chowdhary G.V., Murthy J.M. Valproate-induced hyperammonemic encephalopathy with normal liver function. Neurology India 2005, 53:226-228.
108. Reddy B.A., Bajpe P.K., Bassett A., Moshkin Y.M., Kozhevnikova E., Bezstarosti K., et al. Drosophila transcription factor Tramtrack69 binds MEP1 to recruit the chromatin remodeler NuRD. Molecular and Cellular Biology 2010, 30(21):5234-5244.
109. Reese B.E., Bachman K.E., Baylin S.B., Rountree M.R. The methyl-CpG binding protein MBD1 interacts with the p150 subunit of chromatin assembly factor 1. Molecular and Cellular Biology 2003, 23(9):3226-3236.
110. Rhee I., Bachman K.E., Park B.H., Jair K.W., Yen R.W., Schuebel K.E., et al. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 2002, 416(6880):552-556.
111. Rottach A., Frauer C., Pichler G., Bonapace I.M., Spada F., Leonhardt H. The multi-domain protein Np95 connects DNA methylation and histone modification. Nucleic Acids Research 2010, 38(6):1796-1804.
112. Salman M. Systematic review of the effect of therapeutic dietary supplements and drugs on cognitive function in subjects with Down syndrome. European Journal of Paediatric Neurology 2002, 6(4):213-219.
113. Schones D.E., Cui K., Cuddapah S., Roh T.Y., Barski A., Wang Z., et al. Dynamic regulation of nucleosome positioning in the human genome. Cell 2008, 132(5):887-898.
114. Schwartz S., Meshorer E., Ast G. Chromatin organization marks exon-intron structure. Nature Structural and Molecular Biology 2009, 16(9):990-995.
115. Shahbazian M., Young J., Yuva-Paylor L., Spencer C., Antalffy B., Noebels J., et al. Mice with truncated MeCP2 recapitulate many syndrome features and display hyperacetylation of histone H3. Neuron 2002, 35:243-254.
116. Sharif J., Endo T.A., Toyoda T., Koseki H. Divergence of CpG island promoters: A consequence or cause of evolution?. Development, Growth & Differentiation 2010, 52(6):545-554.
117. Simone C. SWI/SNF: The crossroads where extracellular signaling pathways meet chromatin. Journal of Cellular Physiology 2006, 207(2):309-314.
118. Skene P.J., Illingworth R.S., Webb S., Kerr A.R., James K.D., Turner D.J., et al. Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. Molecular Cell 2010, 37:457-468.
119. Stancheva I., Collins A.L., Van den Veyver I.B., Zoghbi H., Meehan R.R. A mutant form of MeCP2 protein associated with human Rett syndrome cannot be displaced from methylated DNA by notch in Xenopus embryos. Molecular Cell 2003, 12:425-435.
120. Straussman R., Nejman D., Roberts D., Steinfeld I., Blum B., Benvenisty N., et al. Developmental programming of CpG island methylation profiles in the human genome. Nature Structural and Molecular Biology 2009, 16(5):564-571.
121. Sun H.J., Xu X., Wang X.L., Wei L., Li F., Lu J., et al. Transcription factors Ets2 and Sp1 act synergistically with histone acetyltransferase p300 in activating human interleukin-12 p40 promoter. Acta Biochimica et Biophysica Sinica 2006, 38(3):194-200.
122. Suzuki M., Yamada T., Kihara-Negishi F., Sakurai T., Oikawa T. Direct association between PU.1 and MeCP2 that recruits mSin3A-HDAC complex for PU.1-mediated transcriptional repression. Oncogene 2003, 22(54):8688-8698.
123. Tang C.S., Epstein R.J. A structural split in the human genome. PLoS One 2007, 2(7):e603.
124. Temudo T., Rios M., Prior C., Carrilho I., Santos M., Maciel P., et al. Evaluation of CSF neurotransmitters and folate in 25 patients with Rett disorder and effects of treatment. Brain & Development 2009, 31(1):46-51.
125. Thiru A., Nietlispach D., Mott H.R., Okuwaki M., Lyon D., Nielsen P.R., et al. Structural basis of HP1/PXVXL motif peptide interactions and HP1 localisation to heterochromatin. The EMBO Journal 2004, 23:489-499.
126. Tilgner H., Nikolaou C., Althammer S., Sammeth M., Beato M., Valcárcel J., et al. Nucleosome positioning as a determinant of exon recognition. Nature Structural & Molecular Biology 2009, 16(9):996-1001.
127. Ueda T., Postnikov Y.V., Bustin M. Distinct domains in high mobility group N variants modulate specific chromatin modifications. The Journal of Biological Chemistry 2006, 281(15):10182-10187.
128. Urdinguio R.G., Fernandez A.F., Lopez-Nieva P., Rossi S., Huertas D., Kulis M., et al. Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome. Epigenetics 2010, 5:656-663.
129. Urdinguio R.G., Lopez-Serra L., Lopez-Nieva P., Alaminos M., Diaz-Uriarte R., Fernandez A.F., et al. Mecp2-null mice provide new neuronal targets for Rett syndrome. PLoS One 2008, 3:e3669.
130. Urdinguio R.G., Pino I., Ropero S., Fraga M.F., Esteller M. Histone H3 and H4 modification profiles in a Rett syndrome mouse model. Epigenetics 2007, 2:11-14.
131. Urdinguio R.G., Sanchez-Mut J.V., Esteller M. Epigenetic mechanisms in neurological diseases: Genes, syndromes, and therapies. Lancet Neurology 2009, 8:1056-1072.
132. Vecsey C.G., Hawk J.D., Lattal K.M., et al. Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB: CBP-dependent transcriptional activation. The Journal of Neuroscience 2007, 27:6128-6140.
133. Vecsler M., Simon A.J., Amariglio N., Rechavi G., Gak E. MeCP2 deficiency downregulates specific nuclear proteins that could be partially recovered by valproic acid in vitro. Epigenetics 2010, 5:61-67.
134. Vermeulen M., Eberl H.C., Matarese F., Marks H., Denissov S., Butter F., et al. Quantitative interaction proteomics and genome-wide profiling of epigenetic histone marks and their readers. Cell 2010, 142(6):967-980.
135. Wan M., Zhao K., Lee S.S., Francke U. MECP2 truncating mutations cause histone hyperacetylation in Rett syndrome. Human Molecular Genetics 2001, 10:1085-1092.
136. Wang Z., Zang C., Rosenfeld J.A., Schones D.E., Barski A., Cuddapah S., et al. Combinatorial patterns of histone acetylations and methylations in the human genome. Nature Genetics 2008, 40(7):897-903.
137. Wong L.H., McGhie J.D., Sim M., Anderson M.A., Ahn S., Hannan R.D., et al. ATRX interacts with H3.3 in maintaining telomere structural integrity in pluripotent embryonic stem cells. Genome Research 2010, 20:351-360.
138. Wu H., Coskun V., Tao J., Xie W., Ge W., Yoshikawa K., et al. Dnmt3a-dependent nonpromoter DNA methylation facilitates transcription of neurogenic genes. Science 2010, 329(5990):444-448.
139. Wu J.I., Lessard J., Crabtree G.R. Understanding the words of chromatin regulation. Cell 2009, 136(2):200-206.
140. Wu J.I., Lessard J., Olave I.A., Qiu Z., Ghosh A., Graef I.A., et al. Regulation of dendritic development by neuron-specific chromatin remodeling complexes. Neuron 2007, 56(1):94-108.
141. Xin Y., Chanrion B., Liu M.M., Galfalvy H., Costa R., Ilievski B., et al. Genome-wide divergence of DNA methylation marks in cerebral and cerebellar cortices. PLoS One 2010, 5(6):e11357.
142. Xu Y., Wu F., Tan L., Kong L., Xiong L., Deng J., et al. Genome-wide regulation of 5hmC, 5mC, and gene expression by Tet1 hydroxylase in mouse embryonic stem cells. Molecular Cell 2011, 42(4):451-464.
143. Yang X.J., Seto E. HATs and HDACs: From structure, function and regulation to novel strategies for therapy and prevention. Oncogene 2007, 26(37):5310-5318.
144. Yasui D.H., Peddada S., Bieda M.C., Vallero R.O., Hogart A., Nagarajan R.P., et al. Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:19416-19421.
145. Yeo G., Holste D., Kreiman G., Burge C.B. Variation in alternative splicing across human tissues. Genome Biology 2004, 5(10):R74.
146. Yoon H.G., Chan D.W., Reynolds A.B., Qin J., Wong J. N-CoR mediates DNA methylation-dependent repression through a methyl CpG binding protein Kaiso. Molecular Cell 2003, 12(3):723-734.
147. Young J.I., Hong E.P., Castle J.C., Crespo-Barreto J., Bowman A.B., Rose M.F., et al. Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:17551-17558.
148. Yun M., Wu J., Workman J.L., Li B. Readers of histone modifications. Cell Research 2011, 21(4):564-578.
149. Zemach A., McDaniel I.E., Silva P., Zilberman D. Genome-wide evolutionary analysis of eukaryotic DNA methylation. Science 2010, 328(5980):916-919.